Skip to main content

Full coverage

The Black Market for a Lifesaving Cat Drug

4 sources|Diversity: 95%|

By Extra Extra Editorial

Cross-spectrum analysis, synthesized with AI from 4 sources · Updated

How we analyze coverage

A shortage of compounded versions of a veterinary medication used to treat feline hyperthyroidism has created conditions for illegal drug trafficking. Pet owners and veterinarians are turning to black market suppliers to obtain the drug, which is difficult to source through legitimate channels. The shortage stems from regulatory and supply chain constraints that have made the medication scarce despite ongoing demand from cat owners seeking affordable treatment options.

Left· 1 sources

Left-leaning coverage frames this as a systemic failure where regulatory barriers and market consolidation have created artificial scarcity, forcing desperate pet owners into illegal markets. The reporting emphasizes the human cost of supply chain dysfunction and positions the black market as a symptom of deeper problems in pharmaceutical accessibility.

Key Differences

  • Only left-leaning outlets are actively reporting on this story; center and right perspectives are absent from the coverage
  • The framing emphasizes regulatory failure and accessibility barriers rather than market dynamics or consumer choice implications

How this story is being covered

4 reports from 4 outlets95/100 cross-spectrum diversity4 high-reliability sources

Extra Extra has grouped 4 reports on this story from 4 news outlets across the political spectrum. By political lean, that breaks down as 1 left-leaning, 2 center, and 1 right-leaning sources.

With a coverage-diversity score of 95 out of 100, this is one of the more evenly reported stories in our index right now — left, center, and right outlets are all giving it attention.

On reliability, 4 of the 4 rated outlets carry a high or mostly-factual reliability rating (A or B). Ratings are drawn from independent assessments and are meant to help you weigh each report, not to tell you which to trust.

This story has been covered over the span of about 2 days, making it a longer-running thread rather than a single news flash.

Below, the same story is laid out side by side as left, center, and right outlets reported it. Read across the columns and watch what changes: the headline emphasis, which facts lead, the adjectives, and what each side leaves out. The story itself rarely changes — the framing almost always does.

Outlets covering this story: Mother Jones, CNBC, The Economist, RealClearMarkets.


Left(1)

Center(2)

Right(1)

Get this analysis in your inbox

The Daily Spectrum: one email, three perspectives on the day's biggest stories.

Free forever. Unsubscribe anytime. No spam.

New to comparing coverage? Start with our guides to reading the news critically.

Back to Compare